(Q43899490)

27 November 2017

Prognostic factors and risk assessment in chronic myelomonocytic leukemia: validation study of the M.D. Anderson Prognostic Scoring System (English)

1 reference

chronic myelomonocytic leukemia

27 November 2017

1 reference

8

Hagop Kantarjian

1 reference

27 November 2017

6

Jorge Cortes

1 reference

27 November 2017

7

Francis Giles

1 reference

27 November 2017

0 references

2

Sijin Wen

1 reference

27 November 2017

4

Francesco Onida

1 reference

27 November 2017

Miloslav Beran

1

1 reference

27 November 2017

Yu Shen

series ordinal

3

1 reference

27 November 2017

Jaroslav Jelinek

series ordinal

5

1 reference

27 November 2017

language of work or name

1 reference

1 June 2007

1 reference

27 November 2017

1 reference

27 November 2017

48

1 reference

27 November 2017

6

1 reference

27 November 2017

1150-1160

1 reference

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

27 November 2017

1 reference

https://api.crossref.org/works/10.1080%2F10428190701216386

Proposals for the classification of the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701216386

The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701216386

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701216386

Prognosis in chronic myeloid leukaemia: biology of the disease vs. treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701216386

Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701216386

Risk assessment in chronic myelomonocytic leukemia (CMML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701216386

Chronic myelomonocytic leukemia: lost in classification?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701216386

Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701216386

Receptor tyrosine kinase mutations in myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701216386

The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701216386

JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701216386

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701216386

10.1080/10428190701216386

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference